高纯简介
高检督办(2007)102号
《关于高纯案的督办通知》
高纯简介
高纯,1988年毕业于湖南中医学院。曾任中国医药工业公司岳阳中湘康神药业工程师、《中国消费者报》社等媒体特邀记者,在湖南、湖北、广东、浙江、云南、北京等地卧底调查药品注册作假、新药资料和新药证书买卖、假药制造、非法临床试验等黑幕。
1994年,因举报康神药业与湖南省药监局、国家药监局官员相勾结,在新药注册中大规模造假而惨遭打击报复:被停职反省、打伤致残(耻骨骨折移位,伤残捌级)、无故开除,扣上“诬陷领导、破坏生产”的“罪名”。
2000年10月26日,《工人日报》报道此案真相后,罗永清总经理指使人发出《致工人日报党组主编的万言书》,诋毁《工人日报》蔡金和、陈明两位记者;在公司内张贴小字报、召开“批高纯爱企业”会议,党委还出面逼迫高纯妻子与其离婚。
2006年,因举报武汉大学中南医院非法临床试验、销售假药案,被中南医院和湖北省药监局设局栽赃陷害,给高纯扣上“毁坏著名医院和教授荣誉”、“盗窃医院财物”等“罪名”。
2003年4月,因起诉国家药监局官员失职渎职、包庇纵容、参与新药研究作假等事实后,被禁止参加执业药师的考试认证,禁止在医药领域就业,诬陷高纯起诉国家药监局是“与政府作对、与国家为敌”,是“神经病”,身份证内嵌入不良信息而备受欺凌,至今受到社区、街道、信访局、驻京办、公安的全方位监控。
高纯对国家药监局行政诉讼一案,北京市第一中级人民法院、北京市高级人民法院裁定为不予受理、驳回上诉。裁定书号为:(2004)一中行初字第305号、(2004)高行终字第184号。多次向最高人民法院、最高人民检察院申诉,至今没有结果。在国家药监局郑筱萸局长失职渎职等,2007年被判处死刑16年后,仍然得不到公正判决。
高纯从1994年到2007年长达13年的调查分析,揭示了中国新药泛滥、药价虚高与国家药监局郑筱萸局长等一批官员腐败相关联,并于2006年11月发表了《我的中国梦—期待国家药监局能直视存在的问题,尽快拨乱反正,真诚地为人民服务》。
2005年郑筱萸案发免职,2007年对外公开双规并判处死刑,国内外媒体广泛报道高纯事件。高纯被中央电视台、凤凰电视台、南方报系、学习时报等电视台、报刊杂志、网络广泛报道关注。评为中央电视台2006年度3.15红黑榜“质量先锋”、 2007年十大健康英雄、2007年法制新闻人物候选人、2007年中国最具影响力人物候选人、2007年中国魅力50人候选人、2008年感动中国候选人等。
随着媒体的大规模报道,高纯的人身安全受到了更严重的威胁,隐姓埋名求生存。虽躲过数次陷害,但还是被岳阳市驻京办多次非法拘禁和遣送回原籍岳阳监视居住。
李鹏、朱镕基、温家宝三任总理都对高纯案件有过批示,贾春旺总检察长于2007年指示落实政策,最高人民检察院在2007年6月5日,还下发了“高检督办(2007)102号《关于高纯案的督办通知》”,要求为高纯平反昭雪。
高纯无数次去北京,请求按《高检督办通知》落实政策时,官员们都说“高检不可能为高纯下达督办通知”,每一次都被非法截访、非法拘禁、遣送回原籍岳阳。2010年1月9日在北京,高纯被跟踪的岳阳市信访局、驻京办、公安局的周翔等官员非法拘禁、殴打折磨致两肺淤血、胸腔积液、急性心肌梗死、两次休克,在北京天坛医院、阜外医院作了抢救性心脏手术才得以活命。
2022年10月,岳阳市政府才承认《高检督办通知》在岳阳市检察院“确有存档”;2023年6月,湖南省检察院才承认高纯出示的《高检督办通知》复印件是真的。
湖南省检察院以“对上不对下、保密法规、职能变换”等为幌子,拒不告知、复制督办结果,继续忽悠、欺骗,甚至诬陷高纯为“非访”。2023年7月17日,省检莫宏伟处长,叫来芙蓉区马王堆派出所蒋有斌副所长,用手铐铐走高纯,继续对抗最高人民检察院。
2023年9月,高纯再次前往北京,向最高人民检察院、中纪委,继续反映高纯案件,请求肃清郑筱萸余毒,落实“高检督办(2007)102号《关于高纯案的督办通知》”,为高纯平反昭雪。
2007年,高纯创建《中国质量先锋网》31577315.com,任该网站站长。
电话:18975061963
微信:15574841963
Q Q:504874178
网站:www.31577315.com
在线客服
我 的 中 国 梦
—国家药监局能直视存在的问题,尽快拨乱反正,真诚地为人民服务!
从1995年,我就开始关注国家药品监督存在的巨大问题,并向有关职能部门、中纪委、国务院反映这一情况,十一年的呐喊,至今没有获得相关部门的答复。起诉到法院,也是裁定不予受理。十一年来,我时刻都在梦想着:国家药监局能直视存在的问题,尽快拨乱反正,真诚地向人民道歉,真诚地为人民服务!
药监局“敛”收GMP要不得
GMP认证是药监局的形象工程、腐败工程,给药品生产企业和病人带来了巨大的灾难。药监局官员指定企业购买某高价仪器、某高价软件,某设计方案。好不好、用不用,他不管,只要回扣红包到手就行。大部分企业达不了标,只好请专人造假,并大批行贿,以求通过认证。哪一个药品生产企业GMP改造不花掉几百万到几千万?效果怎样?请看“齐二药”事件和华源“欣弗”事件!试问,哪一家没有通过GMP改造?几千家药企就这样被药监局“敛”收了。企业又将GMP改造和行贿的成本转嫁给了消费者。
药监局“泛”卖新药报批资料要不得
当一家企业申报新药资料出笼,马上有几十家或上百家企业跟着上,这中间就有药监局官员的黑手,一套资料要卖几万、几十万、几百万!
药监局“滥”发新药证书要不得
2004年药监局受理了10009种新药申请,美国FDA仅受理了148种。有一个企业一个星期报了两个新药,坦言只要有钱没有办不了的事。一个新药证书叫卖价为几十万到上千万不等,一时中国新药泛滥成灾!
药监局“乱”批高价药要不得
2004年药监局受理的10009种所谓新药中,绝大多数是属于低水平重复生产的,即“老药翻新”、改头换面,换一个包装、一个名称,更换剂型,老药一眨眼变成一种新药,而获得单独定价的权力,不受降价令约束。新药的价格就更离谱,请看下面数据:
环丙:生产成本2.0元以下,政府批准价36元,毛利34元;
欣弗:生产成本2.0元以下,政府批准价38元,毛利36元;
利欧:生产成本6.0以下元,政府批准价148元,毛利142元。
现在人民买不起药,更看不起病,是因为药品太贵了。而药品为何如此之贵呢?是政府乱批高价!
药监局“绿”色通道要不得
到药监局办事,明码标价。快是多少钱,慢是多少钱,决不含糊!企业都提着现金,等候召见。“绿”色通道变成了“黑”色交易大厅!腐败不但穿上了合法的外衣,还成了某些人可歌可颂的政绩!
药监局坑害药师要不得
沿用了几十年的药师职称体系被否认,药品生产流通领域的药师、主管药师、副主任药师、主任药师、药学工程师、药学高级工程师,都要重新考试,获得执业药师资格,否则不能执业。加重了企业和药师的负担,造成了人力、物力、财力的巨大浪费。几十亿元的教材费、培训费、注册费,都到哪里去了?有没有为执业药师做点什么?
药监局作假要不得
药监局官员与企业合谋作假,骗取新药证书、骗取科研成果、骗取科研经费和奖励,最后是害了病人、害了企业、也害了自己。
药监局行政不作为、通风报信和威胁恐吓举报人要不得
对药监局官员与企业合谋作假事件,举报了十一年,上千次,回复是不要再纠缠,令人寒心!药监局官员替被举报人通风报信,甚至还帮助作假者销毁证据,包庇纵容作假,带领被举报单位闯入国家药监局办公室抓人,这是犯罪!
药监局欺骗和报复举报人要不得
药监局派人到举报人家中,骗走药监局官员与企业合谋作假的原始文件,剥夺举报人参加执业药师考试认证资格,比企业的打击报复更令人发指!
药监局干涉法院审案要不得
2003年4月,举报人向北京市第一中级人民法院递交行政诉状,起诉国家药监局行政不作为、通风报信和威胁恐吓举报人后,国家药监局尽各种能事,干涉法院审案,法院最后不得不裁定,不予受理。司法的公正性受到了严重挑衅!
药监局在2005年腐败大曝光后,仍不向媒体、向人民说明案件真实情况要不得
2005年6月,国家药监局原局长郑筱萸被双规;7月,药监局医疗器械司原司长郝和平因涉嫌受贿被刑拘,2006年1月药品注册司司长曹文庄、处长卢爱英、国家药典委员会秘书长中国药品生物制品检定所原副所长王国荣相继被捕;但国家药监局至今没有给媒体和人民一个明了的说法!作为国家药品监督的最高权力机构,理应在第一时间作出说明!
国家药监局郑筱萸局长不判处死刑要不得
国家GMP认证产生巨大腐败,全国药品注册大面积弄虚作假,开辟捞钱的药品注册绿色通道,公开买卖新药注册资料和证书,新药在全国泛滥成灾,让13亿国民吃国家行政机关认可的假药、高价药等等问题,与郑筱萸局长失职渎职、贪污腐败有巨大关联。这是中华民族5000年历史上的最大人为灾难和不幸!这样的恶人郑筱萸局长竟自称“代表国家行使职权”,他若不判处死刑,一定是天怒人怨。
国家药监局有的官员坐庄收利,使国家药监局成了权钱交易的“生产基地”、腐败的温床。药监局,成了老百姓常说的“药奸局”。他们的腐败行为,严重侵犯了人民的利益,损坏了国家的形象,破坏了社会的稳定!
十一年来,我时刻都在梦想着:国家药监局能直视存在的问题,尽快拨乱反正,真诚地向人民道歉,真诚地为人民服务!
梦想何时能成真?
我时刻期待着!
全国人民时刻期待着!
中国质量先锋网 高纯
电话: 020-31577315 18975061963
My Chinese Dream
I wish that the State Food and Drug Administration (Hereafter referred to as “SFDA”) could face the problems, make rectification at the earliest date, and serve the people.
As early as in 1995, the severe problems in medicinal supervision caught my attention. In the past 11 years, I have reported such problems to relevant administrative departments, the Central Commission for Discipline Inspection, and the State Council, but have received no answer from any of them. When I filed a lawsuit for this matter, the court of law rejected the case. For the past 11 years, I have always been dreaming of an outcome: the SFDA could face the existing problems, make rectification and remedy as soon as possible, sincerely apologize to the people, and heartily serve the people.
The SFDA has committed at least the following wrongs:
Make a “GMP Fortune”
The SFDA officials would demand the enterprises to buy certain instruments, software, and design solutions, all at exorbitant prices. They do not care the quality or applicability of such purchases. What they care is only whether they can get the kickback money. Against such a backdrop, every pharmaceutical producer has spent millions and even tens of millions of yuan on its GMP renovation. But what’s the effect? Just think of the “Qiqihar No.2 Pharmaceutical” accident and the “Huayuan Xinfu” accident! Did any of them fail to qualify for the GMP renovation?
Sell application materials for new medicines
Soon after an enterprise has submitted its application materials for a new medicine, tens and even hundreds of enterprises will follow suit with similar applications. It was the SFDA officials who released the monsters from Pandora’s box, charging a price for a set of application materials ranging from tens of thousands of yuan to hundreds of thousands of yuan.
Award certificates for new medicines without restraint
In 2004, SFDA processed and approved the applications for 10009 new medicinal products, whereas the number was only 148 for the FDA of the
Approve exorbitant medicine prices
Among the 10009 so-called new medicines approved by the SFDA in 2004, most were just products of low-level repetition. Such old wine in a new bottle, with a new appearance, a new package, a new dosage form, and even a new name, now became a new product, and thus could be separately priced without being restricted by the government order for cutting down medicine prices. At the same time, the prices of the real new medicines are more absurd, as demonstrated below:
Huanbin (Ciprofloxacin): The production cost is less than 2.0 yuan, but the price approved by the government is 36 yuan, allowing for a gross profit of 34 yuan;
Xinfu (Clindamycin Phosphate Injection): The production cost is less than 2.0 yuan, but the price approved by the government is 38 yuan, allowing for a gross profit of 36 yuan;
Liou (Gatifloxiacin Injection): The production cost is less than 6.0 yuan, but the price approved by the government is 148 yuan, allowing for a gross profit of 142 yuan;
Today, the masses cannot afford medicines, let alone seeing a doctor, because the medicines are too expensive. How come? The government has approved such exorbitant prices!
The corrupted “green” lane
At the SFDA, the services are labeled clearly with prices, one price for faster services and another price for slower services. All the enterprises wait for the services with stacks of banknotes. Here, corruption not only assumes a legal guise, but also becomes the celebrated political achievements of some officials.
Harm the pharmacists
All the pharmacists, supervising pharmacists, vice pharmacy directors, pharmacy directors, pharmaceutical engineers and senior pharmaceutical engineers of pharmaceutical manufacturing and marketing enterprises are all required to take examinations once again to renew their practice licenses, and also receive annual training to sustain such licenses. It is a good thing on the surface. However, calculation tells the truth: this program has been launched for economic benefits! Where does the billions of yuan for the training classes and textbooks go? What services have been provided to the certified pharmacists? Why the qualification of pharmacists working with the SFDA agencies is subject to just a once-off certification?
Commit frauds
A small number of SFDA officials have conspired with some enterprises to commit frauds in order to obtain new medicine certificates, scientific findings, and government grants and prize money for scientific research in a deceitful way, doing harms to the patients, other enterprises, and even themselves.
Neglect its administrative responsibilities, tip the wrongdoers, and threaten the informers
I have exposed the frauds committed jointly by SFDA officials and related enterprises for thousands of times in the past 11 years, only to be warned not to bother again. What a shame! Some SFDA officials tipped the exposed off, tolerated and encouraged frauds, and even helped the falsifiers to destroy the evidences. They even dare to lead the people from the exposed entities into the SFDA offices to seize the informer. Isn’t this a crime?
Deceive and retaliate the informer
The SFDA sent its people to the informer’s home and seized the original evidences that some SFDA officials and related enterprises had conspired to commit frauds, and deprived the informer’s eligibility to participate in the examination for pharmacist certification. Such persecution is more condemnable than the retaliation by the exposed enterprises.
Interfere with judicial hearing
In April 2003, the informer filed an administrative lawsuit with the people’s court of law against the SFDA for its neglecting its administrative duties, tipping off the exposed parties, and threatening and terrorizing the informer. At this, the SFDA made all kinds of efforts to interfere with the judicial hearing, resulting in the court’s ruling rejection of the case. The judicial justice was blatantly challenged!
Refuse to publicize the truth despite exposure of corruption in 2005
In June 2005, Zheng Xiaoyu, former head of the SFDA was subjugated to the “double-designated” (designated time and designated place) investigation. In July of this year, Hao Heping, former Director of SFDA Department of Medical Devices, was arrested for the crime of taking bribery. In January 2006,
Some SFDA officials are selling their power for profit, and thus turning the SFDA into a “production base” of power-money deals and a hotbed of corruption. The SFDA (whose Chinese name in short form reads “yaojianju”) has degraded into “Yaojianju” (Chinese characters meaning “Bureau of Medicine Cheats”) in people’s eyes. Their corruptive practice has severely violated the interests of the people, defiled the image of the government, and jeopardized the social stability.
For 11 years, I have always cherished a dream: the SFDA could face its existing problems, make rectification and remedy as soon as possible, sincerely apologize to the people, and heartily serve the people.
When can my dream come true?
I will be waiting all along!
All Chinese will be waiting all along!
GAO Chun, Yueyang Zhongxiangkangshen Pharmaceutical Company of China National Pharmaceutical Industry Corporation
In Guangzhou, November 18th, 2006
注:此文翻译是覃明 先生。因当时郑筱萸还是副部级官员,网络不能登出,所以当时写的药监局“12个要不得”,只准登出“11个要不得”,翻译也只有“11个要不得“。